1658.0000 10.00 (0.61%)
NSE Aug 11, 2026 15:50 PM
Volume: 420.3K
 

1658.00
0.61%
Deven Choksey
Aurobindo Pharma is well positioned to deliver sustainable double-digit growth, supported by healthy momentum across its US, Europe, India, and Growth Markets businesses, along with a steady cadence of complex product launches.
Aurobindo Pharma has gained 59.10% in the last 1 Year
More from Aurobindo Pharma Ltd.
Recommended